Sofosbuvir in combination with ribavirin or simeprevir: real-life study of patients with hepatitis C genotype 4

BACKGROUND: The discovery of direct-acting antiviral agents (DAA) is an outstanding achievement of modern medicine in the current century. The current study aimed to explore the effectiveness and safety of two regimens sofosbuvir (SOF) in combination with either ribavirin (RBV) or simeprevir (SMV) i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Gastroenterol
Main Authors: Abdel-Moneim, Adel, Aboud, Alaa, Abdel-Gabbar, Mohamed, Zanaty, Mohamed I., Elbary, Amr A. Abd, Ramadan, Mohamed
Formato: Artigo
Idioma:Inglês
Publicado em: Hellenic Society of Gastroenterology 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6302204/
https://ncbi.nlm.nih.gov/pubmed/30598598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20524/aog.2018.0327
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados